Susvimo 100 mg/mL
Ranibizumab · INJECTION, SOLUTION · Genentech, Inc.
No Recall History
Plain English
Susvimo is a injection, solution containing ranibizumab at 100 mg/mL, taken intravitreal. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Susvimo
- Generic Name
- Ranibizumab
- NDC Code (Product)
50242-078- Manufacturer
- Genentech, Inc.
- Strength
- 100 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- BLA761197
- Drug Class
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Marketing Start
- 10/22/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Susvimo used for?
Susvimo contains Ranibizumab. It is a injection, solution taken intravitreal. Consult your doctor for specific uses.
Is Susvimo a controlled substance?
Susvimo is not classified as a controlled substance by the DEA.
What is the generic name for Susvimo?
The generic name for Susvimo is Ranibizumab. There are 8 other brand versions of Ranibizumab.
What is the NDC code for Susvimo 100 mg/mL?
The NDC (National Drug Code) for Susvimo 100 mg/mL is 50242-078, listed by Genentech, Inc..